Literature DB >> 25721971

Quenching resonance energy transfer (QRET): a single-label technique for inhibitor screening and interaction studies.

Kari Kopra1, Harri Härmä2.   

Abstract

The increased number of therapeutic targets has led to a growing need for screening methods enabling possible inhibitor compound selection. Information for new therapeutic targets has been found mostly from sequencing of the human genome but this knowledge cannot be directly converted into clinically relevant drug molecules. After target identification, the multistep drug development process takes many years and hundreds of millions of dollars are spent without certainty of the outcome. The first and the most critical step in the drug development process is hit selection. The optimal high throughput screening method should provide the highest possible number of true positive hits for further studies and lead discovery. The result should be achieved with low material consumption in a rapid and automated process. Radioactive label based methods are sensitive, but due to the problems arising from the radioactivity, luminescence-based methods have become increasingly popular in screening. In this review, the time-resolved luminescence based quenching resonance energy transfer (QRET) technique is discussed for primary screening.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25721971     DOI: 10.1016/j.nbt.2015.02.007

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  4 in total

1.  Thermal Dissociation Assay for Time-Resolved Fluorescence Detection of Protein Post-Translational Modifications.

Authors:  Ville Eskonen; Natalia Tong-Ochoa; Salla Valtonen; Kari Kopra; Harri Härmä
Journal:  ACS Omega       Date:  2019-09-24

2.  Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring.

Authors:  Kari Kopra; Emmiliisa Vuorinen; Maria Abreu-Blanco; Qi Wang; Ville Eskonen; William Gillette; Arto T Pulliainen; Matthew Holderfield; Harri Härmä
Journal:  Anal Chem       Date:  2020-03-09       Impact factor: 6.986

3.  Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.

Authors:  Kari Kopra; Iraida Sharina; Emil Martin; Harri Härmä
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

4.  Single-Peptide TR-FRET Detection Platform for Cysteine-Specific Post-Translational Modifications.

Authors:  Ville Eskonen; Natalia Tong-Ochoa; Leena Mattsson; Moona Miettinen; Mika Lastusaari; Arto T Pulliainen; Kari Kopra; Harri Härmä
Journal:  Anal Chem       Date:  2020-09-16       Impact factor: 6.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.